Literature DB >> 18422733

Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz's disease.

K Yamada1, M Kawano, R Inoue, R Hamano, Y Kakuchi, H Fujii, M Matsumura, Y Zen, M Takahira, A Yachie, M Yamagishi.   

Abstract

Mikulicz's disease (MD) is gaining acceptance as an immunoglobulin G4 (IgG4)-related disease characterized by bilateral lacrimal and salivary gland swelling. The aetiology of MD and other IgG4-related diseases is still unclear. The present work was performed to study the clonality of infiltrating IgG4-positive plasma cells in lacrimal glands and circulating peripheral blood cells in patients with MD, and compare the clonal relationship between infiltrating and circulating IgG4 positive cells. Total cellular RNA was extracted from the lacrimal glands and peripheral blood in five MD patients. Reverse transcription polymerase chain reaction was performed with primers specific for activation-induced cytidine deaminase (AID) and for Ig VH and IgG4. Sequences of Ig VH were compared with the structure of Ig VH of the lacrimal glands and the peripheral blood cells. AID was expressed to varying degrees in lacrimal glands of all MD patients. Most IgG4-positive cells infiltrating lacrimal glands and in peripheral blood were polyclonal, although several clonally related pairs were detected. In one patient, two of the circulating IgG4 VH4-59 clones shared identical CDR3 sequences with the clones within the lacrimal glands. In conclusion, while most tissue-infiltrating and circulating IgG4-positive cells in MD are polyclonal, some clonally related IgG4 positive cells exist between lacrimal gland and peripheral blood, accounting for the clinical features of MD as an IgG4-related disease involving multiple organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422733      PMCID: PMC2453205          DOI: 10.1111/j.1365-2249.2008.03651.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.

Authors:  Capucine Daridon; Jacques-Olivier Pers; Valérie Devauchelle; Christine Martins-Carvalho; Pascal Hutin; Yvon-Louis Pennec; Alain Saraux; Pierre Youinou
Journal:  Arthritis Rheum       Date:  2006-07

Review 2.  Competence and competition: the challenge of becoming a long-lived plasma cell.

Authors:  Andreas Radbruch; Gwendolin Muehlinghaus; Elke O Luger; Ayako Inamine; Kenneth G C Smith; Thomas Dörner; Falk Hiepe
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

3.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

5.  Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas.

Authors:  D W Bahler; J A Miklos; S H Swerdlow
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

6.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.

Authors:  Amel Meraouna; Geraldine Cizeron-Clairac; Rozen Le Panse; Jacky Bismuth; Frederique Truffault; Chantal Tallaksen; Sonia Berrih-Aknin
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

7.  Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

Authors:  Yoh Zen; Takahiko Fujii; Kenichi Harada; Mitsuhiro Kawano; Kazunori Yamada; Masayuki Takahira; Yasuni Nakanuma
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

8.  Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells.

Authors:  Motohiro Kojima; Bence Sipos; Wolfram Klapper; Olaf Frahm; Hans-Christian Knuth; Akio Yanagisawa; Giuseppe Zamboni; Toshio Morohoshi; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

9.  Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.

Authors:  Pooja Takhar; Christopher J Corrigan; Lyn Smurthwaite; Brian J O'Connor; Stephen R Durham; Tak H Lee; Hannah J Gould
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

10.  Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome.

Authors:  Michele Bombardieri; Francesca Barone; Frances Humby; Stephen Kelly; Mark McGurk; Peter Morgan; Stephen Challacombe; Salvatore De Vita; Guido Valesini; Jo Spencer; Costantino Pitzalis
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

View more
  11 in total

1.  Infraorbital nerve swelling associated with autoimmune pancreatitis.

Authors:  Tomoharu Watanabe; Yasunari Fujinaga; Satoshi Kawakami; Tomoko Hatta; Hideaki Hamano; Shigeyuki Kawa; Masumi Kadoya
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

Review 2.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

3.  B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.

Authors:  Xiao-Na Wang; Xin Ge; Jing Li; Xiao Liu; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

Review 4.  T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Autoimmune Dis       Date:  2022-06-20

5.  Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.

Authors:  Jian-Min Ma; Yi-Xin Cui; Xin Ge; Jing Li; Jin-Ru Li; Xiao-Na Wang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

6.  Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance.

Authors:  Kazuhiro Kiyama; Daisuke Kawabata; Yuji Hosono; Koji Kitagori; Naoichiro Yukawa; Hajime Yoshifuji; Koichiro Omura; Takao Fujii; Tsuneyo Mimori
Journal:  Arthritis Res Ther       Date:  2012-04-24       Impact factor: 5.156

7.  The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases.

Authors:  Kai-Ming Li; Man-Hua Xu; Xia Wu; Wei-Min He
Journal:  Onco Targets Ther       Date:  2020-06-17       Impact factor: 4.147

8.  Serum trypsin and TCR as novel markers for predicting disease activity in IgG4-related disease.

Authors:  Wang Fengqing; Yi Qiang; Gao Feng; Zhuang Zehao; Ma Yuefei; Chen Jing; Wang Guina; Hu Bing; Zheng Jing; Zhang Jingjing; Lu Danfeng; Ha Rui; Liu Qi-Cai
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

9.  DNA Microarray Analysis of Submandibular Glands in IgG4-Related Disease Indicates a Role for MARCO and Other Innate Immune-Related Proteins.

Authors:  Miho Ohta; Masafumi Moriyama; Takashi Maehara; Yuka Gion; Sachiko Furukawa; Akihiko Tanaka; Jun-Nosuke Hayashida; Masaki Yamauchi; Noriko Ishiguro; Yurie Mikami; Hiroto Tsuboi; Mana Iizuka-Koga; Shintaro Kawano; Yasuharu Sato; Tamotsu Kiyoshima; Takayuki Sumida; Seiji Nakamura
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  LatY136F knock-in mouse model for human IgG4-related disease.

Authors:  Kazunori Yamada; Masahiko Zuka; Kiyoaki Ito; Keishi Mizuguchi; Yasushi Kakuchi; Tamehito Onoe; Yasunori Suzuki; Masakazu Yamagishi; Shozo Izui; Marie Malissen; Bernard Malissen; Mitsuhiro Kawano
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.